Replies to post #120643 on Biotech Values

[investorgold2002]

yes. but as a layman, I am optimistic on MNTA's chances of winning over inequitable conduct

"
Don't you think the fact that they did not adequately discuss 2 clinical studies where they concluded Copolymer of 11K-23K DA mol weight is safe during the prosecution of patent, is MATERIAL ENOUGH for patentability of this patent which claims "Copolymer of 5-9KDA mol weight is less toxic""

Applying the BUT FOR Standard:

Also, but for undisclosed references of studies on 11K-23KDA which concluded they were safe, this patent claim "Copolymer of 5-9KDA mol weight is less toxic" would not have been allowed by PTO